MiR-31 and miR-128 regulates Poliovirus receptor-related 4 mediated measles virus infectivity in tumors
Oncolytic measles virus strains are currently being evaluated in several clinical trials, as a promising novel oncolytic platform. Poliovirus receptor-related 4 (PVRL4) was recently identified as a potent measles virus (MV) receptor; however, its regulation is not yet understood. Increased levels of PVRL4 protein were observed in cell membrane, cytoplasm and nuclei of glioblastoma, breast and ovarian tumor clinical samples with no significant change in PVRL4 mRNA levels in glioblastoma and breast cancer compared with their corresponding control samples, suggesting that PVRL4 is likely post-transcriptionally regulated.
Source: Molecular Oncology - Category: Cancer & Oncology Authors: Hirosha Geekiyanage, Evanthia Galanis Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Measles | Ovarian Cancer | Ovaries